Prescriptions rose sharply after widespread media attention early in 2025

Prescribing rates for leucovorin among youth with autism was 24-fold higher in November 2025 compared with the average prescribing rate from January 2023 to January 2025,…

Prescriptions rose sharply after widespread media attention early in 2025

The FDA recently declined to endorse leucovorin for autism, citing a lack of strong evidence for it.